The use of anticoagulants in the management of atrial fibrillation among general practices in England.

PubWeight™: 1.90‹?› | Rank: Top 3%

🔗 View Article (PMC 3717828)

Published in Heart on February 07, 2013

Authors

Campbell Cowan1, Richard Healicon, Ian Robson, W Robert Long, James Barrett, Matthew Fay, Keith Tyndall, Chris P Gale

Author Affiliations

1: 1NHS Improvement-Heart, Leicester, UK. Campbell.cowan@leedsth.nhs.uk

Articles citing this

Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol (2014) 1.39

Can we trust studies using audit software? A case study of atrial fibrillation audit. Br J Gen Pract (2015) 1.38

Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort. Br J Gen Pract (2015) 1.16

Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) database. Clin Res Cardiol (2014) 0.86

Automated Risk Assessment for Stroke in Atrial Fibrillation (AURAS-AF)--an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomised controlled trial. Trials (2013) 0.84

Untreated atrial fibrillation in the United Kingdom: Understanding the barriers and treatment options. J Saudi Heart Assoc (2014) 0.80

Improving anticoagulation in atrial fibrillation: observational study in three primary care trusts. Br J Gen Pract (2014) 0.80

Results from the Registry of Atrial Fibrillation (AFABE): Gap between Undiagnosed and Registered Atrial Fibrillation in Adults--Ineffectiveness of Oral Anticoagulation Treatment with VKA. Biomed Res Int (2015) 0.78

The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation. J Stroke (2016) 0.77

Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation. Vasc Health Risk Manag (2015) 0.77

Anticoagulant treatment in German family practices - screening results from a cluster randomized controlled trial. BMC Fam Pract (2014) 0.76

Recent time trends in incidence, outcome and premorbid treatment of atrial fibrillation-related stroke and other embolic vascular events: a population-based study. J Neurol Neurosurg Psychiatry (2015) 0.75

Stroke prevention for patients with atrial fibrillation: improving but not perfect yet. Heart (2013) 0.75

Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study. BMC Cardiovasc Disord (2016) 0.75

Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries. EBioMedicine (2017) 0.75

Screening for Atrial Fibrillation using Economical and accurate TechnologY (SAFETY)-a pilot study. BMJ Open (2017) 0.75

Impact of age on long-term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient management. Br J Clin Pharmacol (2016) 0.75

Is self-monitoring an effective option for people receiving long-term vitamin K antagonist therapy? A systematic review and economic evaluation. BMJ Open (2015) 0.75

How prepared are pharmacists to support atrial fibrillation patients in adhering to newly prescribed oral anticoagulants? Int J Clin Pharm (2017) 0.75

Factors Influencing Oral Anticoagulant Prescribing Practices for Atrial Fibrillation. J Stroke (2017) 0.75

Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD. BMJ Open (2017) 0.75

Articles cited by this

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA (2001) 24.12

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23

Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA (2001) 16.98

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest (2009) 14.06

Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med (2007) 10.87

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet (2007) 10.10

Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J (2005) 4.46

Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med (2010) 4.15

Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? J Thromb Haemost (2008) 2.73

Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database. Heart (2001) 2.41

Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart (2005) 2.24

Using prescribing indicators to measure the quality of prescribing to elderly medical in-patients. Age Ageing (2003) 2.20

Newly detected atrial fibrillation and compliance with antithrombotic guidelines. Arch Intern Med (2007) 2.00

Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol (2005) 1.97

Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). Eur Heart J (2006) 1.91

Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme. Am Heart J (2008) 1.80

Risk stratification schemes, anticoagulation use and outcomes: the risk--treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation. Heart (2011) 1.54

Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey. Br J Gen Pract (2012) 1.46

Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000-2009. Heart (2012) 1.38

Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy. Thromb Res (2007) 1.11

Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care. Stroke (2005) 1.06

Are atrial fibrillation guidelines altering management? A community based study. Scott Med J (2005) 0.87

Influence of age on the prescription of vitamin K antagonists in outpatients with permanent atrial fibrillation in France. Pharmacoepidemiol Drug Saf (2007) 0.83

Articles by these authors

There's an app for that: content analysis of paid health and fitness apps. J Med Internet Res (2012) 2.97

Dietary fiber intake and risk of first stroke: a systematic review and meta-analysis. Stroke (2013) 2.14

Systematic review of care intervention studies for the management of incontinence and promotion of continence in older people in care homes with urinary incontinence as the primary focus (1966-2010). Geriatr Gerontol Int (2012) 1.43

Ethical pitfalls can be hard to avoid. BMJ (2004) 1.39

Feedback from educational supervisors and trainees on the implementation of curricula and the assessment system for core medical training. Clin Med (2008) 1.05

Association of frontal QRS-T angle--age risk score on admission electrocardiogram with mortality in patients admitted with an acute coronary syndrome. Am J Cardiol (2011) 0.98

Impact of hospital proportion and volume on primary percutaneous coronary intervention performance in England and Wales. Eur Heart J (2010) 0.97

Predictors of nonresponse to treatment in primary care patients with dysthymia. Gen Hosp Psychiatry (2002) 0.95

Do outcomes from transcatheter aortic valve implantation vary according to access route and valve type? The UK TAVI Registry. J Interv Cardiol (2013) 0.87

Correlates of remission in primary care patients treated for minor depression. Gen Hosp Psychiatry (2002) 0.86

Persistent geographical disparities in the use of primary percutaneous coronary intervention in 120 European regions: exploring the variation. EuroIntervention (2013) 0.86

Engaging with the clinical data transparency initiative: a view from the National Institute for Cardiovascular Outcomes Research (NICOR). Heart (2012) 0.85

Automated Risk Assessment for Stroke in Atrial Fibrillation (AURAS-AF)--an automated software system to promote anticoagulation and reduce stroke risk: study protocol for a cluster randomised controlled trial. Trials (2013) 0.84

Systematic review of the management of incontinence and promotion of continence in older people in care homes: descriptive studies with urinary incontinence as primary focus. J Adv Nurs (2010) 0.83

The effects of cannabis use expectancies on self-initiated cannabis cessation. Addiction (2013) 0.83

An assessment of composite measures of hospital performance and associated mortality for patients with acute myocardial infarction. Analysis of individual hospital performance and outcome for the National Institute for Cardiovascular Outcomes Research (NICOR). Eur Heart J Acute Cardiovasc Care (2013) 0.82

Systematic review of descriptive studies that investigated associated factors with the management of incontinence in older people in care homes. Int J Older People Nurs (2011) 0.81

Contemporary roles of registries in clinical cardiology: when do we need randomized trials? Expert Rev Cardiovasc Ther (2014) 0.81

The impact of posttraumatic stress disorder on cannabis quit success. Am J Drug Alcohol Abuse (2015) 0.80

Anticoagulation in AF. Anticoagulation uptake remains poor in high risk patients. BMJ (2011) 0.80

Discovery of MLL1 binding units, their localization to CpG Islands, and their potential function in mitotic chromatin. BMC Genomics (2013) 0.79

Impact of left ventricular function and transaortic gradient on outcomes from transcatheter aortic valve implantation: data from the UK TAVI Registry. EuroIntervention (2016) 0.77

Privacy for defecation and fecal incontinence in older adults. J Wound Ostomy Continence Nurs (2006) 0.77

Factors with the management of incontinence and promotion of continence in older people in care homes. J Adv Nurs (2013) 0.76

Seek referral to a heart rhythm specialist for atrial fibrillation. BMJ (2012) 0.75

Geriatric medicine: the Wirral experience. Clin Med (2007) 0.75

Treating and managing atrial fibrillation. Nurs Times (2013) 0.75

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J (2020) 0.75

Impact of diabetes on long-term mortality after presentation with acute myocardial infarction. J Cardiovasc Med (Hagerstown) (2011) 0.75

Incontinence and falls in older people: is there a link? Nurs Times (2005) 0.75

Opportunistic screening for atrial fibrillation. Nurs Times (2013) 0.75

Are Sex Differences in Outcomes of Patients with ACS from Observational Registries Similar to the Findings from Randomized Clinical Trials? Curr Pharm Des (2016) 0.75